FDA approves Medtronic's latest DBS - MassDevice
Medtronic Percept PC neurostimulator BrainSense technology
Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic]
Medtronic (NYSE:MDT) said today that it has received FDA approval for the Percept PC deep brain stimulation (DBS) system.

The medical device giant is touting Percept PC’s BrainSense technology, which is designed to sense and record brain signals while delivering DBS therapy to people with neurological disorders such as Parkinson’s disease.

BrainSense enables more personalized, data-driven neurostimulation treatment, according to Medtronic.

The FDA approval of the Percept PC neurostimulator means that health providers can use it to treat symptoms associated with Parkinson’s disease, essential tremor, primary dystonia, epilepsy and obsessive-compulsive disorder. The device gained the CE Mark in January.

Mayo Clinic in Rochester, Minn., will be the first in the United States to implant the newly approved device.

“Our goal is for patients to regain independence, and we know that DBS can significantly improve motor function in people with Parkinson’s disease compared to standard medication alone,” said Mayo Clinic neurologist Dr. Bryan Klassen, M.D., in a news release. “We can now more precisely tailor therapy to the individual needs of each patient based on data from neuronal activity.”

DBS is an individualized therapy delivered from a small pacemaker-like device, placed under the skin of the chest or abdomen, to send electrical signals through very thin wires (leads) to a targeted area in the brain related to the symptoms of a neurological disorder.

“With movement disorders like Parkinson’s disease, even sharing a meal and holding utensils can be a challenge,” said John Lehr, president & CEO of the Parkinson’s Foundation. “We’re excited by new treatments and clinical advancements that let people with Parkinson’s live fuller, more complete, lives.”

“There is nothing that can replace clinical judgment in treating patients. For the first time, this technology gives clinicians feedback directly from the DBS patient’s brain,” said Mike Daly, VP and general manager of the Medtronic’s brain modulation business. “With such data-driven, patient-specific insights, we believe it can change the standard of care.”

RSS From Medical Design & Outsourcing

  • MedTech Europe gives proposed European Health Union a partial nod
    MedTech Europe has endorsed a new plan to strengthen the EU’s response to future pandemics and public health emergencies, with a few caveats. European Commission President Ursula von der Leyen outlined the plan to create a European Health Union in her state of the union speech on Nov. 11. The plan is a response to… […]
  • Advanced Powder Products wins at the Powder Metallurgy Design Excellence Awards Competition
    Advanced Powder Products earlier this year won the grand prize in the medical/dental category at the 2020 Powder Metallurgy Design Excellence Awards Competition, sponsored by the Metal Powder Industries Federation (MPIF). APP (Philipsburg, Pa.) won for its guide tube for use in dental surgery. Here’s more from APP about the guide tube: “This unique component… […]
  • GE Healthcare acquires Prismatic Sensors at its photon-counting CT sensors
    GE Healthcare  (NYSE:GE) said today that it has acquired Prismatic Sensors, a Swedish startup with deep silicon detector technology for photon-counting computed tomography (PCCT). The financial terms of the deal were not disclosed. GE Healthcare expects to close the deal in January 2021; its held a minority position in the company since 2017. Photon-counting CT technology,… […]
  • November 2020 Issue: The Big 100 — Medtech’s 100 Largest Players
    The 20 largest medical device companies in the world The 12 largest medtech employers of 2020 – and what their employees really think How major medtech companies are responding to the looming EU MDR How medtech has fought COVID-19 This year has been such a challenging time for the U.S. and the world that 2019… […]
  • Appeals court nixes GSK’s petition for new trial in Vectura patent spat
    The Federal Circuit Court has rejected Glaxo Smith Kline’s (NYSE:GSK) petition for a new trial in a patent case brought by British inhaler company Vectura. The circuit court upheld a May 2019 jury verdict in U.S. District Court for the District of Delaware, awarding Ventura $89.7 million damages for the period from August 2016 through December 2018 for an… […]
  • Penumbra clot-retrieval system gains new FDA nod
    Penumbra (NYSE:PEN) announced today that the FDA has granted expanded clearance for its Indigo aspiration catheter system, Lightning 12. Indigo Lightning is now indicated for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems as well as for the treatment of pulmonary embolism, according to the Alameda, Calif.-based… […]
  • BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system
    Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform… […]
  • B. Braun halts certain Aesculap knee implants
    B. Braun is notifying customers who purchased certain Aesculap knee systems to temporarily cease implanting them while the company addresses a “possible malfunction.” In a Nov. 16 letter sent to customers worldwide, the company said a “locally accumulated number of aseptic loosenings have been reported to us in connection with the univation X system. ln the… […]
  • Key steps for medical device manufacturers effective CAPA management
    By Sarah Fitzgerald and Stewart Eisenhart, Emergo Group Ensuring adequate processes for corrective and preventative action (CAPA) management is a critical step for medical device manufacturers implementing ISO 13485:2016 or other quality management systems. However, effective CAPA management can prove a perennial challenge even to larger, more mature manufacturers. Get the full story here at… […]
  • Depleted hospital capital accounts require medtechs to be`flexible’
    As hospitals battle another surge in COVID-19, medical device companies have to worry about more than temporary reductions in elective surgeries. Hospitals struggling to account for every dollar are beginning to push for different ways to select and pay for new medical technology, particularly large capital items like robotic surgery systems, according to a review… […]
  • Explorer says AR, AI will improve surgeon-sales rep connections
    Explorer Surgical, one of several companies working to established remote connections between surgeons and advisors located outside the operating room, introduced a suite of audio/video functionality that it says will established “unprecedented” levels of communications. The Chicago-based startup says its platform will include augmented reality. According to a release, the HIPAA-compliant system will allow proxies,… […]